Amiodarone: Clinical trials

Current Opinion in Cardiology

Volumn 15, Issue 1, 2000, Pages 64-72

  Naccarelli, Gerald V ^a   Wolbrette, Deborah L ^a   Patel, Hemantkumar M ^a   Luck, Jerry C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ARGENTINA; CANADA; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DOUBLE BLIND PROCEDURE; GERMANY; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; POLAND; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SECONDARY PREVENTION; SPAIN; SUPRAVENTRICULAR TACHYCARDIA;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CLINICAL TRIALS; DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0033959297     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200001000-00009     Document Type: Review

References (40)

1. 1 Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE: Adjunctive drug therapy of acute myocardial infarction: evidence from clinical trials. N Engl J Med 1996, 335:1660-1667.
2. 2 Naccarelli GV, Wolbrette DL, Dell'Orfano JT, Patel HM, Luck JC: A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. J Cardiovasc Electrophysiol 1998, 9:864-891.
3. 3 Echt DS, Liebson PR, Mitchell LB, Peters RW, Oblas-Manno D, Barker AH, et al. and the CAST Investigators: Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781-788.
4. 4 Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al.: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996, 348:7-12.
5. 5 Impact Research Group: International mexiletine and placebo antiarrhythmic coronary trial I. Report on arrhythmia and other findings, J Am Coll Cardiol 1984, 4:1148-1163.
6. 6 Julian DG, Prescott RJ, Jackson FS, Szekely P: Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982, 1:1142-1147.
7. 7 The Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992, 327:227-233.
8. 8 Teo KK, Yusuf S, Furberg CD: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993, 270:1589-1595.
9. 9 Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990, 16:1711-1718.
10. 10 Pfisterer ME, Kiowski W, Brunner H, Burckhardt D, Burkart F: Long-term benefit of 1 year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 1993, 87:309-311
11. 11 Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, et al.: Effect of amiodarone on mortality after myocardial infarction: a double-blind placebo-controlled, pilot study. J Am Coll Cardiol 1992, 20:1056-1062.
12. 12 Lopez F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A, for the SSSD Investigators: Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. Am J Cardiol 1993, 72:1243-1248.
13. 13 Julian DG, Camm AJ, Franglin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators: Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997, 349:667-674.
14. 14 Cairns, JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators: Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997, 349:675-682.
15. 15 Sim I, McDonald KM, Lavori PW, Norbutas CM, Hlatky MA: Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997, 96:2823-2829.
16. 16 Amiodarone Trials Meta-Analysis Investigators: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997, 350:14317-1424.
17. 17 Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992, 20:527-532.
18. 18 Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, et al.: Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996, 28:1458-1463.
19. 19 Cleland JGF, Dargie HJ, Findlay JN, Wilson JT: Clinical hemodynamic and antiarrhythmic effects of long-term treatment with amiodarone of patients in heart failure. Br Heart J 1987, 57:436-445.
20. 20 Cleland JGF, Dargie HJ, Ford I: Mortality in heart failure: clinical variables of prognostic value. Br Heart J 1987, 58:572-582.
21. 21 Nicklas JM, McKenna WJ, Stewart RA, Mickelson JK, Das SK, Schork MA, et al.: Prospective double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991, 122:1016-1021.
22. 22 Garguicheveich JJ, Ramos JL, Gambarte A, Gentile A, Hauad S, Scapin O, et al.: Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine pilot study of sudden death and amiodarone (EPAMSA). Am Heart J 1995, 130:494-500.
23. 23 Doval HC, Nul DR, Grancelli HO, Perrone SV, Borman GR, Curiel R, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) : Randomized Trial of Low-Dose Amiodarone in Severe Congestive Heart Failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994, 344:493-498.
24. 24 Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al., for the GESICA-GEMA Investigators: Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation 1996, 94:3198-3203.
25. 25 Nul DR, Doval HC, Grancelli HO, Varini SD, Soifer S, Perrone SV, et al., on behalf of the GESICA-GEMA Investigators: Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997, 29:1199-1205.
26. 26 Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995, 333:77-82.
27. 27 Singh SN, Fisher SG, Carson PE, Fletcher RD, for the CHF STAT Investigators: Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 1998, 32:942-947.
28. 28 Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN, for the Department of Veterans Affairs CHF-STAT Investigators: Spontaneous conversion and maintenace of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation 1998, 98:2574-2579.
29. 29 Nisam S, Mower M: ICD trials: an extraordinary means of determining patient risk? PACE 1998, 21:1341-1346.
30. 30 Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933-1940.
31. 31 Buxton AE, Fisher JD, Josephson ME, Lee K, Pryor DB, Prystowsky EN, et al., the MUSTT Investigators: Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 1993, 36:215-226.
32. 32 Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, et al.: Cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation 1998, 97:2129-2135.
33. 33 The CASCADE Investigators: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol 1993, 72:280-287.
34. 34 Siebels J, Cappato R, Ruppel R, Schneider MAE, Kuck KH, and the CASH Investigators: Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 1993, 72:109F-113F.
35. 35 The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
36. 36 Connolly S, Gent M, Roberts R, Doorian P, Green MS, Klein GJ, et al.: Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol 1993, 72:103F-108F.
37. 37 Curtis AB, Hallstrom AF, Klein RC, Nath S, Pinski SL, Epstein AE, et al., for the AVID Investigators: Influence of patient characteristics in the selection of patients for defibrillator implantation (the AVID registry). Am J Cardiol 1997, 79:1185-1189.
38. 38 Kim SG, Hallstrom A, Love JC, Rosenberg Y, Powell J, Roth J, et al., for the AVID Investigators: Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs. Implantable Defibrillators (AVID) trial and nonrandomized registry patients. Am J Cardiol 1997, 80:454-457.
39. 39 Anderson JL, Hallstrom AP, Epstein AE, Pinski SI, Rosenberg Y, Nora MO, et al., and the AVID Investigators: Design and results of the Antiarrhythmics vs Implantable Defibrillaors (AVID) registry. Circulation 1999, 99:1692-1699.
40. 40 Wever EFD, Hauer RNW, van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, et al.: Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995, 91:2195-2203.